Related Experiment Video
Updated: Jun 9, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Glucose control in severely thermally injured pediatric patients: what glucose range should be the target?
Marc G Jeschke1, Robert Kraft, Fatemeh Emdad
1Shriners Hospitals for Children, Biochemistry and Molecular Biology, Galveston, TX, USA. majeschk@utmb.edu
Insights
Targeting a blood glucose level of 130 mg/dL in severely burned pediatric patients is associated with improved outcomes. This glucose range reduces infections, sepsis, and mortality, while attenuating inflammatory responses.
Area of Science:
- Critical care medicine
- Pediatric burn management
- Metabolic control in trauma
Background:
- Tight glycemic control in intensive care units has shown detrimental outcomes.
- Evidence suggests current tight euglycemic control protocols may be harmful.
- No established glucose range is currently recommended for thermally injured patients.
Purpose of the Study:
- To identify optimal blood glucose levels for improved outcomes in severely burned pediatric patients.
- To evaluate the association between specific glucose ranges and patient morbidity and mortality.
- To guide glucose management strategies in critical burn care.
Main Methods:
- A cohort of 208 severely burned pediatric patients (burns >30% TBSA) was analyzed.
- Statistical models determined daily average and 6 AM glucose targets linked to outcomes.
- Patients were stratified into good vs. poor glucose control groups for comparative analysis.
Main Results:
- Hyperglycemia strongly predicts adverse hospital outcomes.
- A daily 6 AM glucose level of 130 mg/dL and a daily average of 140 mg/dL correlate with better outcomes.
- Patients with glucose levels around 130 mg/dL exhibited reduced inflammation, infection, sepsis, and mortality.
Conclusions:
- A target blood glucose level of 130 mg/dL is suggested for severely burned patients.
- This target range may mitigate risks associated with hypoglycemia and improve survival.
- Optimizing glucose control is crucial for managing hypermetabolic and inflammatory responses post-burn.
Objective:
To determine which glucose levels are associated with improved morbidity and mortality in thermally injured patients.
Summary Background Data:
Tight euglycemic control was rapidly implemented in intensive care units around the world, but there is increasing evidence that tight euglycemic control is associated with detrimental outcomes. Currently, no study exists that indicates which glucose range should be targeted.
Methods:
Two-hundred and eight severely burned pediatric patients with burns over 30% of their total body surface area were included in this trial. Several statistical models were used to determine the daily average and 6 AM glucose target that were associated with improved morbidity and mortality. Patients were then divided into good glucose controlled and poor glucose controlled patients and demographics, clinical outcomes, infection, sepsis, inflammatory, and hypermetabolic responses were determined.
Results:
Statistical modeling showed that hyperglycemia is a strong predictor of adverse hospital outcome and that daily 6 am glucose level of 130 mg/dL and daily average glucose levels of 140 mg/dL are associated with improved morbidity and mortality postburn. When patients were divided into good glucose control and poor glucose control, we found that patients with glucose levels of 130 mg/dL exert attenuated hypermetabolic and inflammatory responses, as well as significantly lower incidence of infections, sepsis, and mortality compared with patients with poor glucose control, P < 0.05.
Conclusions:
Given the controversy over glucose range, glucose target, and risks and detrimental outcomes associated with hypoglycemia we suggest that in severely burned patient's blood glucose of 130 mg/dL should be targeted.
Related Concept Videos
Hypoglycemia and Glucagon
Hypoglycemia
Hyperglycemia
Hyperosmolar Hyperglycemic State
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
